2026-10-25
ABM Industries clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,944 +1.18%
S&P 7,385 +0.42%
GOLD $4,067 −1.12%
BTC $75,586 −0.47%
VIX 25.28 −10.29%
latest tape · as of 18:01 UTC
The Screen · Industrials · Specialty Business Services
ABM Industries Incorporated
ABM · the NYSE · USD · Market cap $3.2B · 113,000 employees
ABM Industries Incorporated, through its subsidiaries, engages in the provision of facility maintenance, engineering and infrastructure solutions in the United States and internationally.
Not yet scored53.67 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 18:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price53.67 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readAccumulation, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.07)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $65.29 to $108.81, base estimate $67.50 (screen dated 2026-11-05).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.07, read 2026-11-05
- Ethical screen not yet scored
Price53.67 USD
Fair value67.50
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation48.97+9.6% to today ✓Markup gives way to Accumulation first Accumulation read since August
2026-10-02Read Markup49.43+8.6% to today ✓Markdown gives way to Markup
2026-08-27Read Markdown47.77+12.4% to today Accumulation gives way to Markdown first Markdown read since July
2026-08-20Read Accumulation48.54+10.6% to today ✓Markdown gives way to Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
ABM Industries Incorporated holds its Accumulation at $53.67. The statistical read favours the buyers, held for 11 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 11 days |
| Price at the screen | $53.67 |
| Valuation | 19.83 trailing · 12.57 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.66 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 31.85% | Below 33% | Interest-bearing debt is just 31.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 29.89% | Below 49% | Money owed to the company is 29.9% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
ABM Industries clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
ABM Industries clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 19% discount to our $67.50 fair value, 4.20% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 20.5% discount to the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits +1% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere our models see it going: fair-value estimate $67.50, with a range of $65.29 to $108.81, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 4%-growth business trading at just 12.6x forward earnings. That is a 19% discount to our $67.50 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 7 analysts rate it Buy with a $54.00 average target, about 1% above the screened price.
| Forward P/E | 12.6xexpensive even after accounting for its growth |
| Trailing P/E | 19.8xreasonably valued |
| EPS, trailing | 2.76 |
| EPS, forward | 4.35 |
| Revenue growth | +4.2%slow but positive growth |
| Profit margin | 1.8%barely profitable |
| Return on equity | 9.2%a modest return on shareholder capital |
| FCF yield | 8.77% |
| Dividend yield | 253.00% |
| Debt to equity | 1.05a meaningful debt load worth watching |
| Current ratio | 1.42adequate liquidity, worth monitoring |
| Beta | 0.66steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 36.96 - 55.32 |
| Market cap | $3.2B |
| Employees | 113,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeABM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-01
Accumulation $53.48
+2.3% Entry 22
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51.
2026-10-25
Accumulation $52.28
+3.0% Entry 21
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51.
2026-10-18
Accumulation $50.76
+3.7% Entry 20
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51.
2026-10-11
Accumulation · changed $48.97
-0.9% Entry 19
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51.
2026-10-02
Markup · changed $49.43
+3.5% Entry 18
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51.
2026-09-08
Markdown $47.77
+0.0% Entry 17
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-06
Markdown $47.77
+0.0% Entry 16
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-05
Markdown $47.77
+0.0% Entry 15
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-03
Markdown $47.77
+0.0% Entry 14
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-02
Markdown $47.77
+0.0% Entry 13
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (7 analysts) rates it buy, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- ABM Announces Executive Leadership Changes Yahoo Finance · 9d ago
- Is Rollins Stock About To Rebound? Yahoo Finance · 11d ago
- How Investors May Respond To ABM Industries (ABM) UK Public Sector Framework Win Yahoo Finance · 14d ago
- Strength Seen in AMN Healthcare (AMN): Can Its 8.9% Jump Turn into More Strength? Yahoo Finance · 14d ago
- Could Cintas Stock Survive Slower Growth? Yahoo Finance · 15d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
CBZCBIZ, Inc.
MMSMaximus, Inc.
FAFirst Advantage Corporation
AZZAZZ Inc.
TICTIC Solutions, Inc.
CMPRCimpress plc
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $39.39 | +12.9% | · | $1,129 | +12.9% |
| 2 months | $39.23 | +13.4% | · | $1,134 | +13.4% |
| 3 months | $38.38 | +15.9% | $0.29 | $1,166 | +16.6% |
| 6 months | $46.42 | -4.2% | $0.58 | $971 | -2.9% |
| 1 year | $46.61 | -4.6% | $1.11 | $978 | -2.2% |
| 2 years | $47.90 | -7.1% | $2.09 | $972 | -2.8% |
| 3 years | $43.43 | +2.4% | $2.98 | $1,093 | +9.3% |
| 5 years | $43.77 | +1.6% | $4.58 | $1,121 | +12.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ABM does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.